Effect on Migraine Frequency of Combined Anti-oxidant Therapy: The MIGRANT Study.
NCT02629536
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Migraine, Headaches
Interventions
DRUG:
N-acetyl cysteine 600 mg, VitE 250 IU, VitC 500 mg tablet
Sponsor
University of Notre Dame Australia